Web Stats Provided By Google Analytics

Monday, April 28, 2014

Genervon Successfully Completes its Phase 2a Clinical Trial for ALS

Genervon Biopharmaceuticals LLC today announced that it has successfully completed its Phase 2a clinical trial for amyotrophic lateral sclerosis disease modification.

http://ift.tt/QTZVxi

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts